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1 |  BACKGROUND
Miscarriage, the spontaneous loss of pregnancy before the 
22nd week of gestation or fetus weighing less than 500 g, is 
the most common complication of pregnancy (WHO, 1997). 
An estimated 70% of conceptions are miscarried, most of 
which are lost before the missed menstrual period (Macklon, 
Geraedts, & Fauser, 2002). Accordingly, approximately 10% 
of clinically recognized pregnancies result in a miscarriage.
Recurrent miscarriage (RM) is considered to be a distinct 
clinical entity defined as the occurrence of more than one 
miscarriage in a particular woman. However, the minimum 
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Abstract
Background: Our aim was to conduct a comprehensive genetic evaluation using the 
combination of QF‐PCR (quantitative fluorescence polymerase chain reaction) and 
aCGH (array comparative genomic hybridization) for the detection of the frequency 
and type of chromosome aberrations in recurrent miscarriage (RM) in the clinical 
setting.
Methods: This retrospective study was conducted on 73 first‐trimester products of 
conception (POC) between September 2014 and February 2017. The POCs were 
collected from 73 women with at least one previous miscarriage and analyzed for 
chromosomal anomalies using QF‐PCR and aCGH as part of the routine clinical 
evaluation.
Results: Chromosome aberrations were detected in 52/73 POCs (71.2%), of which 
41 (56.2%) were identified by QF‐PCR and an additional 11 (15.1%) by aCGH. 
Numerical aberrations constituted 92.3% of abnormalities, with trisomies as the most 
common subtype (72.9%). Causative structural aberrations were found in three sam-
ples (5.8%). The frequency of chromosome aberrations was not dependent on the 
number of previous miscarriages, whereas it significantly increased with advanced 
maternal age.
Conclusion: Our results confirm that chromosome aberrations are the most common 
cause of RM and that QF‐PCR and aCGH combination should be included in the 
routine genetic analysis of POCs of couples with miscarriage.
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number of miscarriages (≥2 or ≥3), their order (consecu-
tive or nonconsecutive), and partner specificity (with the 
same partner or not) required for the diagnosis of RM dif-
fer between guidelines recommended by professional so-
cieties (Jauniaux, Farquharson, Christiansen, & Exalto, 
2006; Practice Committee of the American Society for 
Reproductive Medicine, 2012; Royal College of Obstetricians 
& Gynaecologists, 2011). Regardless of these discrepancies, 
the established causes include uterine anomalies and anti-
phospholipid syndrome in women, as well as balanced struc-
tural rearrangements in either partner. Collectively, these 
factors can be identified in 40% of couples at the most, leav-
ing the majority without an identifiable cause (Stephenson, 
Awartani, & Robinson, 2002).
On the other hand, the increasing number of recent inves-
tigations suggests that embryonic chromosome aberrations 
are the most common cause of RM, similar to sporadic mis-
carriages (Hodes‐Wertz et al., 2012; Sugiura‐Ogasawara et 
al., 2012). Unfortunately, comprehensive genetic analysis of 
products of conception (POC) is still not a common practice 
despite the fact that it would reduce the number of diagnos-
tic evaluations performed in reproductive couples with RM 
(Brezina & Kutteh, 2014) and also decrease the incidence 
of idiopathic RM (Foyouzi, Cedars, & Huddleston, 2012; 
Liu et al., 2015; Marquard, Westphal, Milki, & Lathi, 2010; 
Sugiura‐Ogasawara et al., 2012).
Although the standard chromosome analysis of POCs 
has been performed using the G‐banding method, the short-
comings of this cell‐based analysis include high rate of cell 
culture failure, poor sample quality, low band resolution, 
and maternal cell or microbial contamination (Robberecht, 
Schuddinck, Fryns, & Vermeesch, 2009; Sahoo et al., 2017; 
Shah et al., 2017). Conversely, molecular cytogenetic meth-
ods, which do not require cell cultures, have a higher res-
olution and improve turnaround time. Recently, a clinical 
algorithm for efficient cytogenomic analysis of POCs and 
fetal tissues has been proposed, which includes quantitative 
fluorescent polymerase chain reaction (QF‐PCR) followed by 
array comparative genomic hybridization (aCGH) on POCs 
with normal or uninformative results of QF‐PCR (Morgen, 
Maire, & Kolomietz, 2012; Wou et al., 2016). This “no‐cul-
ture or uncultured protocol” reduces failure rate, increases 
diagnostic yield, and is cost‐effective in comparison to tra-
ditional karyotyping (Donaghue et al., 2017; Morgen et al., 
2012; Wou et al., 2016). In previous studies, karyotyping of 
POCs of couples with RM was conducted using either G‐
banding, different molecular cytogenetic methods (e.g., flu-
orescence in situ hybridization, multiple ligation‐dependent 
probe amplification), or aCGH but there are no previous re-
ports in which the combination of QF‐PCR and aCGH was 
systematically used in the clinical setting. Therefore, the aim 
of the present study was to investigate the frequency and 
type of chromosome aberrations in POCs of couples who 
previously had at least one miscarriage using the QF‐PCR 
and aCGH strategy.
2 |  PATIENTS AND METHODS
2.1 | Editorial policies and ethical 
considerations
Informed consent for genetic testing was obtained from all 
women.
2.2 | Sample collection
Products of conception were obtained by dilatation and curet-
tage from 73 consecutively admitted women with at least one 
previous miscarriage between September 2014 and February 
2017. All POCs were referred to the Clinical institute of med-
ical genetics, University medical centre Ljubljana, Slovenia. 
Twenty‐nine women were admitted at second miscarriage, 
32 at third miscarriage, and 12 at fourth to 10th miscarriage. 
All miscarriages occurred in the first trimester. None of the 
women had endocrine, metabolic, autoimmune or other sys-
temic disorders, venous or arterial thrombosis, antiphospho-
lipid syndrome or uterine anatomic abnormalities.
2.3 | Genetic testing
The protocol used for genetic analysis of POCs in our study 
is shown in Figure 1. This protocol is part of the routine ge-
netic testing service provided at the Clinical institute of medi-
cal genetics, University medical centre Ljubljana, Slovenia 
and Institutional review board approval was therefore not 
obtained. The DNA was extracted from chorionic villi ac-
cording to the manufacturer's protocol using Qiagen Mini kit 
(Qiagen). Quality and concentration parameters of the DNA 
F I G U R E  1  The protocol used for genetic analysis of products of 
conception
QF-PCR
Basic panel
(45,X0, T13, T18, T21, triploidy)
negative positive
QF-PCR
Broad panel
(T15, T16, T22)
aCGH
negative positive
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were measured with NanoDrop 2000c spectrophotometer 
(Thermo Fisher Scientific Inc.) and Qubit 2.0 fluorometer 
(Life Technologies Inc.).
2.3.1 | QF‐PCR
The analysis of aneuploidy of chromosomes 13, 15, 16, 18, 
21, 22, X, and Y was based on determining the number of 
copies of selected genetic markers on each chromosome using 
QF‐PCR method. We used Aneufast Multiplex QF‐PCR kit 
(molGENTIX SL) containing 21 genetic markers with a high 
degree of heterozygosity (five genetic markers for autosomes 
13, 18, and 21, three markers for pseudoautosomal regions 
of chromosomes X and Y, one on the X chromosome‐linked 
marker and markers on amelogenin, and SRY on chromo-
some Y). Devyser Extend M1 v2 kit by Devyser (Sweden) 
was used to analyze aneuploidy of chromosomes 15, 16, and 
22, containing 15 genetic markers (five genetic markers for 
each autosome 15, 16, 22, and one additional marker on the 
chromosome 18) in one single QF‐PCR reaction (Devyser 
Extend v2, Art.No.:8‐A015.2, Devyser Extend M1 v2, Art.
No.:8‐A015.2‐M1, For in vitro Diagnostic Use, Instructions 
for Use: Devyser Extend v2, CE‐IVD, 7‐A025‐EN, version 
2016‐05‐03).
Diagnosis of normal samples was acceptable if at least 
two markers on each chromosome had clear heterozygous 
pattern within the normal range. According to the manufac-
turer's instructions, markers indicated aneuploidy if at least 
two markers showed a normal triallelic profile or trisomic 
diallelic patterns and that other markers for a specific chro-
mosome had an uninformative character (were homozygous).
2.3.2 | Array CGH
DNA was processed according to Agilent protocol (Version 
7.3 March 2014) using a commercially available male and 
female genomic DNA (Agilent Technologies, Human 
Reference DNA, Male and Female) or in‐house DNA ref-
erence mix as a reference DNA. Agilent SurePrint G3 
Unrestricted CGH ISCA v2, 8 × 60 K microarrays were used 
which provide a practical average resolution of 100 kb. Array 
images were acquired using Agilent laser scanner G2565CA, 
image files were quantified using Agilent Feature extraction 
software for Cytogenomics 3.0, and analyzed with Agilent 
Cytogenomics 3.0 software (Agilent Technologies).
2.3.3 | Classification of results
Called copy number variants (CNV) were aligned with known 
aberrations in publically available databases—ClinGen 
(http://dbsea rch.clini calge nome.org/searc h/), DECIPHER 
(Database of Chromosomal Imbalance and Phenotype in 
Humans using Ensembl Resources https ://decip her.sanger.
ac.uk/), Database of Genomic Variants (DGV) (http://dgv.
tcag.ca/dgv/app/home), as well as with the in‐house database 
of detected variants and their clinical significance, ascer-
tained by the trained analysts. All called CNVs were classified 
into three groups, benign, variants of unknown significance 
(VOUS), and pathogenic, according to ACMG Standards and 
Guidelines (Kearney, Thorland, Brown, Quintero‐Rivera, & 
South, 2011).
Parental studies were performed in cases when unbal-
anced structural rearrangements were identified to confirm 
their origin.
2.4 | Statistical analysis
Statistical analyses were performed using Statistica for 
Windows, version 12 (StatSoft, Inc.). The distribution 
of numerical variables (maternal age) was tested using 
Kolmogorov–Smirnov test. Mann–Whitney U test was used 
for the comparison of the mean maternal ages in relation to 
karyotype results. Pearson's Chi‐squared (χ2) test was used 
to examine differences between the number of abnormal and 
normal karyotypes according to the number of previous mis-
carriages. p < .05 were considered statistically significant.
3 |  RESULTS
The overall results of the QF‐PCR and aCGH are summa-
rized in Table 1. Chromosome aberrations were detected in 
52 of the 73 POCs evaluated (71.2%), of which 41 (56.2%) 
were identified by QF‐PCR and an additional 11 (15.1%) 
by aCGH. Numerical aberrations constituted the majority 
(92.3%) of abnormalities, with trisomies as the most com-
mon subtype (72.9%). Causative structural aberrations were 
found in three samples (5.8%). In addition, one VOUS was 
detected.
3.1 | Results of QF‐PCR
In the 41 POCs with numerical aberrations detected by basic 
and broad panel QF‐PCR (Table 2), the three most frequent 
aberrations were trisomy 22 (10/41; 24.4%), trisomy 16 
(10/41; 24.4%), and triploidy (7/41; 17.1%). The common 
trisomies (13, 21) were present in five POCs (12.1%) and 
monosomy X in six POCs (14.6%). In addition, three POCs 
had trisomy 15 (7.3%). The only case of trisomy 18 was fur-
ther analyzed and confirmed by aCGH as mosaicism due to 
uninformative results of QF‐PCR.
3.2 | Results of aCGH
Array CGH was performed subsequently in 31 POCs with 
negative results of QF‐PCR and one POC in whom trisomy 
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18 was suspected (Table 3). However, one POC with nega-
tive results was excluded from analysis due to the insufficient 
amount of DNA sample. An additional seven aneuploidies 
were detected, including trisomy 2, 3, 9, 10, and 12, as 
well as two mosaic trisomies of chromosomes 10 and 18. 
Furthermore, aCGH also revealed three large unbalanced 
structural rearrangements, inherited from the balanced pa-
rental translocations. Finally, a de novo terminal deletion of 
chromosome 11q25 (size 2.44 ± 0.09 Mb) was detected in 
one male POC, which was classified as a VOUS after com-
parison with CNV databases.
3.3 | Chromosome aberrations in relation 
to the number of previous miscarriages and 
maternal age
There were no statistically significant differences in the total 
number of abnormal and normal karyotypes according to the 
number of previous miscarriages, that is, between two and 
three miscarriages (Χ2 = 0.56, p = .456), two, three, and four 
or more miscarriages (Χ2 = 2.40, p = .301), nor two and three 
or more miscarriages (Χ2 = 0.06, p = .811; Table 2).
The mean maternal ages according to different karyotype 
results is shown in Table 4. The mean age was higher in moth-
ers with abnormal karyotype results than those with normal 
results, although the p‐value was of borderline statistical 
TABLE 1  Summary results of genetic analysis of 73 products of 
conception
 
Results/N (%)  
Positive Negative Uninformative
QF‐PCR basic 
panel
18 (24.6) 54 (74.0) 1 (1.4)
QF‐PCR broad 
panel
23 (31.5) 31 (42.5)  
aCGHa 11 (15.1) 20 (27.4)  
Total aberra-
tions detected
52 (71.2)    
Numerical 
aberrations
48 (92.3)    
Trisomies 35 (72.9)    
Triploidy 7 (14.6)    
Monosomy X 6 (12.5)    
Unbalanced 
structural 
aberrations
3 (5.8)    
Variants of 
unknown 
significance
1 (1.9)    
Abbreviations: aCGH, array comparative genomic hybridization; POC, products 
of conception; QF‐PCR, quantitative fluorescent polymerase chain reaction.
aOne POC was excluded from analysis due to the insufficient amount of DNA sample. 
T A B L E  2  Frequency and types of numerical chromosome aberrations detected by QF‐PCR
Karyotype
Order of miscarriage/N (%)
Second Third Fourth to 10th Total
Monosomy X 2 (13.3) 1 (5.0) 3 (42.9) 6 (14.6)
Triploidy 2 (13.3) 5 (25.0)   7 (17.1)
Trisomies
Trisomy 13 1 (6.7)     1 (2.4)
Trisomy 18 1 (6.7)a      
Trisomy 21 1 (6.7) 2 (10.0) 1 (14.2) 4 (9.8)
Trisomy 15 1 (6.7) 2 (10.0)   3 (7.3)
Trisomy 16 3 (20.0) 3 (15.0) 3 (42.9) 10 (24.4)
Trisomy 22 4 (26.6) 6 (30.0)   10 (24.4)
Total abnormal 14 (48.3) 20 (62.5) 7 (58.3) 41 (56.1) 
Total normal 14 (48.3) 12 (37.5) 5 (41.7) 31 (42.5) 
Total uninformative 1 (3.4)     1 (1.4) 
Statistical significance (total abnormal 
vs. normal)
Χ2 = 0.56, p = .456b    
Χ2 = 2.40, p = .301c    
Χ2 = 0.06, p = .811d    
Abbreviations: aCGH, array comparative genomic hybridization; QF‐PCR, quantitative fluorescent polymerase chain reaction.
aUninformative result, which was further analyzed and confirmed by aCGH. 
bTwo versus three miscarriages. 
cTwo versus three versus four or more miscarriages. 
dTwo versus three or more miscarriages. 
Bold values indicate statistical significance (total abnormal vs. normal). 
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significance (p =  .049). Furthermore, the average maternal 
age was significantly higher in the group POCs with triso-
mies in comparison to both the POCs of normal karyotype 
(p = .007) and to all other karyotypes (p < .001).
4 |  DISCUSSION
Our results confirm that chromosome aberrations are the 
most common cause of miscarriage and that QF‐PCR and 
aCGH testing strategy is efficient in the genetic analysis of 
POCs. Both of these findings have the potential to advance 
the diagnostic management of couples with miscarriage.
We detected an overall 69.9% of causative numerical 
and structural chromosome aberrations in our study sam-
ple, which is among the highest reported frequencies in 
RM. The frequency of chromosome aberrations in previ-
ous studies conducted exclusively on POCs of couples with 
RM varies depending on the method used for their detec-
tion. For example, the frequencies range from 24.6% to 
64% using G‐banding (Carp et al., 2001; Choi, Lee, Park, 
Jeong, & Moon, 2014; Grande et al., 2012; Hassold, 1980; 
Liu et al., 2015; Ogasawara, Aoki, Okada, & Suzumori, 
2000; Stephenson et al., 2002; Stern, Dorfmann, Gutiérrez‐
Najar, Cerrillo, & Coulam, 1996; Sugiura‐Ogasawara et 
T A B L E  3  Frequency and types of chromosome aberrations detected by aCGH
Order of 
miscarriage Number of POCs testeda Result
Total abnor-
malities/ N (%)
Second 15 Numerical aberrations:
arr[hg19] (2)×3
arr[hg19] (3)×3
arr[hg19] (12)×3
arr[hg19] (18)×2−3
6 (40)
Unbalanced structural rearrangements:
arr[hg19] 11q13.1q25(64,238,508–134,868,407)×3,17p13
.3p13.1(76,263–3,696,032)×1
arr[hg19] 3p26.3p25.3(93,949–10,002,512)×1,7q32
.1q36.3(128,187,082–159,124,131)×3
Third 12 (−1)b Numerical aberrations:
arr[hg19] (9)×3
arr[hg19] (10)×3
arr[hg19] (10)×2–3
5 (45.4)
Unbalanced structural rearrangements:
arr[hg19] 2q22.3q37.3(146,419,130–243,068,396)×3,13q31
.3q34(92,126,915–115,092,648)×1 mat
VOUS:
11q25 deletion de novo
Fifth 1 Normal 0
Sixth 1 Normal
Seventh 1 Normal
Eight 1 Normal
Tenth 1 Normal
Total 31   11 (35.5)
Abbreviations: aCGH, array comparative genomic hybridization; POC, products of conception; QF‐PCR, quantitative fluorescent polymerase chain reaction; VOUS, 
variants of unknown significance.
aAll POCs had normal QF‐PCR results except for one POC in the category of two miscarriages in whom uninformative results were obtained. 
bOne POC was excluded from analysis due to the insufficient amount of DNA sample. 
T A B L E  4  Chromosome aberrations in relation to maternal age
  Mean agea SD p valued,e p valued,f
Totalb 34.00 4.75    
Normalc 32.20 4.32    
Abnormalb 35.00 4.81 .049  
Monosomy Xc 32.50 4.32 .738 .541
Triploidy 32.71 4.27 .638 .588
Trisomy 35.49 4.82 .007 <.001
a72 women. 
bMedian. 
cMean. 
dMann–Whitney U test. 
eMean age in relation to age of normal karyotypes. 
fMean age in relation to age of all other karyotypes. 
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al., 2012; Sullivan, Silver, LaCoursiere, Porter, & Branch, 
2004; Zhang et al., 2014), 66.6% using aCGH (Ozawa et 
al., 2016), and 55.9 to 70.7% using single‐nucleotide poly-
morphism array (Robberecht et al., 2012; Maslow et al., 
2015; Wang et al., 2017). In addition, preimplantation 
genetic diagnosis performed using fluorescence in situ 
hybridization or aCGH revealed a high incidence of embry-
onic chromosome aberrations, ranging from 41% to 70.7% 
(Hodes‐Wertz et al., 2012; Pellicer et al., 1999; Rodrigo 
et al., 2014; Rubio et al., 2003; Rubio et al., 2009; Vidal 
et al., 1998). The percentage of numerical and unbalanced 
structural aberrations obtained in our study (92.3% vs. 
5.8%) is also in accordance with those of previous studies. 
Moreover, the classification of numerical aberrations into 
subcategories further confirmed that trisomies are the most 
common abnormalities in POCs of couples with RM, fol-
lowed by triploidy and monosomy X. The most prevalent 
trisomies are the nonviable trisomy 16 and 22 (Carp et al., 
2001; Carp et al., 2006; Choi et al., 2014; Hassold, 1980; 
Robberecht et al., 2012; Stephenson et al., 2002). Our re-
sults are also consistent with previous findings that the fre-
quency of chromosome aberrations significantly increases 
with advanced maternal age, which is especially notable 
for trisomies (Grande et al., 2012; Marquard et al., 2010; 
Sugiura‐Ogasawara et al., 2012).
On the other hand, unbalanced structural rearrangements 
comprise less than 10% of all chromosome aberrations in 
POCs of couples with RM (Carp et al., 2006; Choi et al., 
2014; Liu et al., 2015; Ozawa et al., 2016; Robberecht et 
al., 2012; Stephenson et al., 2002; Sugiura‐Ogasawara et al., 
2012; Sullivan et al., 2004; Wang et al., 2017). We detected 
large rearrangements in three POCs resulting in partial triso-
mies of chromosomes 11q13, 7q32, and 2q22, as well as par-
tial monosomies of chromosomes 17p13, 3p26, and 13q31, 
respectively. Considering that all chromosomal gains and 
losses were larger than 30 and 3 Mb, respectively, they can 
be classified as pathological variants that led to miscarriage. 
We subsequently performed selective karyotyping of parents 
and confirmed that all three rearrangements were inherited 
from one of the parents. The incidence of balanced structural 
aberrations in reproductive couples who have had at least two 
miscarriages is between 2% and 6% ++(Barber et al., 2010; 
De la Fuente‐Cortes et al., 2009; El‐Dahtory, 2011; Franssen 
et al., 2005; Fryns & Van Buggenhout 1998; Gonçalves et 
al., 2014; Jaslow, Carney, & Kutteh, 2010; Karim et al., 
2017; Kochhar, & Ghosh, 2013; Sheth et al., 2013; van den 
Boogaard et al., 2011). Although translocations are hetero-
geneous in couples with RM, certain chromosome segments 
appear to be affected more often than others. Accordingly, 
the segments affected in our study sample were previously 
described either in partners with RM who were carriers of 
balanced translocations or POCs who inherited an unbal-
anced rearrangement (Fan et al., 2016; Ghazaey et al., 2015; 
Goddijn et al., 2004; Iyer, Vyas, Ranjan, & Saranath, 2009; 
Kochhar & Ghosh, 2013; Shimokawa et al., 2006). Among 
them, the 7q32 breakpoint is one of the most frequently re-
ported in the literature.
In addition to its ability to detect large unbalanced 
structural rearrangements, aCGH has the potential to 
identify submicroscopic imbalances (Dhillon et al., 2014). 
However, despite the fact that various small‐size de novo 
and inherited CNVs have been discovered in POCs of cou-
ples with RM, their contribution to developmental failure 
is mostly unknown (Rajcan‐Separovic et al., 2010; Wang 
et al., 2017). It is estimated that the incidence of such 
VOUS in miscarriage is 2% (Dhillon et al., 2014). In our 
study, a single de novo terminal deletion of chromosome 
11q25 was detected (size 2.44  ±  0.09  Mb). The deleted 
region harbors nine OMIM genes, which have not been 
associated with human diseases when present in a sin-
gle copy. However, larger 11q terminal deletions lead to 
the 11q terminal deletion disorder or Jacobsen syndrome 
(OMIM #147791), the characteristics of which do not in-
clude spontaneous abortions. We identified one descrip-
tion of a similar deletion in the ClinGen database, which 
was classified as pathogenic (nssv575983) in a patient 
with a coordination disorder. In addition, one similar de-
letion (ID259180) was found in the DECIPHER database 
in a patient with mental retardation, which was inherited 
from a healthy parent. Finally, we found no description of 
similar deletions in the DGV.
Despite the fact that the standpoint on whether RM 
should be defined as two or three or more miscarriages 
is still not unanimous, the results of our study indicate 
that the frequency of chromosome aberrations is not sta-
tistically different in relation to the number of previous 
miscarriages, corroborating the findings of several previ-
ous studies (Goldstein, Svirsky, Reches, & Yaron, 2017; 
Stern et al., 1996). Also, the frequency of chromosome 
aberrations in RM appears to be similar to those observed 
in sporadic miscarriages (Goldstein et al., 2017; Grande 
et al., 2012; Stern et al., 1996). Nevertheless, regardless 
of the number of previous miscarriages, chromosome ab-
errations are the major factor leading to undesired preg-
nancy loss. Additionally, whether women with a previous 
aneuploid miscarriage are at an increased risk of future 
chromosome aberrations is still a matter of debate. The 
conflicting results might be the consequence of the fact 
that conclusions are based on the evaluation of a small 
number of patients conducted in a small number of stud-
ies. Recurrent aneuploidy has been reported to occur in 
10%–76.2% of cases and does not appear to be related to 
a single chromosome (Bianco, Caughey, Shaffer, Davis, 
& Norton, 2006; Hassold, 1980; Hassold, Jacobs, Pettay, 
& Rao, 1988; Sugiura‐Ogasawara et al., 2012; Sullivan 
et al., 2004).
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The results of our comprehensive genetic analyses of 
POCs of couples with RM could have significant clinical 
implications considering that we confirmed that the QF‐
PCR and aCGH is an efficient testing strategy in the clinical 
practice. Due to the high frequency of chromosome aberra-
tions, we suggest that a standard genetic analysis of POCs is 
performed in all miscarriages. Consequently, such analysis 
would enable proper genetic counseling and, no less im-
portant, reduce the number of unnecessary pharmaceuticals 
that are usually administered to women with RM regardless 
of therapeutic indications. The application of this testing 
strategy will alter the ratio of couples with explained and 
truly unexplained RM, which will inevitably improve the 
clinical approach to couples with RM. Even though paren-
tal cytogenetic studies are included in the routine diagnostic 
evaluation of RM, cost analysis studies indicate that obtain-
ing a karyotype of POCs of couples with RM as a first step 
in diagnostic evaluation is less costly than an extensive pa-
rental work‐up (Bernardi, Plunkett, & Stephenson, 2012; 
Foyouzi et al., 2012; Petracchi, Paez, & Igarzabal, 2017).
Future studies should focus on the discovery of the origin of 
aneuploidies and long‐term follow‐up of couples to explore the 
true frequency of recurrent aneuploidy. In addition, next‐gen-
eration sequencing could be conducted on POCs with negative 
results after both QF‐PCR and aCGH to determine the contri-
bution of the smallest DNA variants to miscarriage.
5 |  CONCLUSIONS
Chromosome aberrations were detected in 71.2% of POCs 
of couples with RM using QF‐PCR and aCGH testing strat-
egy. Numerical aberrations comprised more than 92.3% of 
all abnormalities. The frequency of chromosome aberrations 
was not dependent on the number of previous miscarriages, 
whereas it significantly increased with advanced maternal 
age. We suggest that the genetic analysis of POCs using QF‐
PCR and aCGH is introduced in the routine clinical evalua-
tion of couples with miscarriage.
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